F15.280 Other stimulant dependence with stimulant-induced anxiety disorder

Name of the Condition

• Other stimulant dependence with stimulant-induced anxiety disorder (ICD-10 Code: F15.280)

Summary

This condition involves a pattern of stimulant use (excluding caffeine and nicotine) that leads to clinically significant impairment or distress, characterized by dependence and the presence of a stimulant-induced anxiety disorder. The anxiety symptoms arise directly from stimulant use or withdrawal.

Causes

Stimulant dependence is often caused by prolonged use of stimulant substances, such as amphetamines or prescription stimulants, which alter brain chemistry and reinforce compulsive use behaviors. The co-occurring anxiety disorder may result from the direct effects of stimulants on the central nervous system or withdrawal symptoms.

Risk Factors

• Factors that may increase risk include a history of substance use disorder, genetic predisposition, high-stress environments, and co-occurring mental health conditions like anxiety or depression.

Symptoms

• Symptoms may include a strong desire to use stimulants, difficulty controlling use, withdrawal symptoms (e.g., fatigue, depression), and continued use despite negative impacts on health or social functioning. The stimulant-induced anxiety disorder may present with additional symptoms like excessive worry, restlessness, or panic attacks.

Diagnosis

Diagnosis is based on a comprehensive evaluation, including patient history, physical examination, and assessment of substance use patterns to determine if criteria for dependence are met. The presence of anxiety symptoms must be linked to stimulant use or withdrawal.

Treatment Options

• Treatment may involve behavioral therapies (e.g., cognitive-behavioral therapy), medications to manage withdrawal or cravings, and support programs. Anxiety symptoms may be addressed with targeted therapies or medications as needed.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence and co-occurring anxiety. Regular follow-up is important to monitor treatment response, manage withdrawal, and address relapse risks. Long-term support may improve outcomes.

Complications

• Complications may include worsening anxiety, social or occupational impairment, physical health issues (e.g., cardiovascular problems), and increased risk of overdose or other substance use disorders.

Lifestyle & Prevention

• Strategies to reduce risk include avoiding stimulant use, seeking stress management techniques, and addressing underlying mental health conditions. Early intervention for substance use can prevent progression to dependence.

When to Seek Professional Help

Seek help if stimulant use is causing distress, interfering with daily life, or leading to anxiety symptoms. Professional evaluation is recommended for persistent or worsening symptoms.

Tips for Medical Coders

Document the presence of stimulant dependence and the specific stimulant-induced anxiety disorder. Ensure clinical details support the diagnosis and link the anxiety to stimulant use or withdrawal. Follow coding guidelines for substance use disorders with co-occurring conditions.